309 related articles for article (PubMed ID: 21916992)
1. Management of ascites in cirrhosis.
Wong F
J Gastroenterol Hepatol; 2012 Jan; 27(1):11-20. PubMed ID: 21916992
[TBL] [Abstract][Full Text] [Related]
2. An update on the pathogenesis and clinical management of cirrhosis with refractory ascites.
Neong SF; Adebayo D; Wong F
Expert Rev Gastroenterol Hepatol; 2019 Apr; 13(4):293-305. PubMed ID: 30791777
[TBL] [Abstract][Full Text] [Related]
3. ePTFE-TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis.
Bucsics T; Hoffman S; Grünberger J; Schoder M; Matzek W; Stadlmann A; Mandorfer M; Schwabl P; Ferlitsch A; Peck-Radosavljevic M; Trauner M; Karner J; Karnel F; Reiberger T
Liver Int; 2018 Jun; 38(6):1036-1044. PubMed ID: 29091351
[TBL] [Abstract][Full Text] [Related]
4. Management of refractory ascites.
Singhal S; Baikati KK; Jabbour II; Anand S
Am J Ther; 2012 Mar; 19(2):121-32. PubMed ID: 21192246
[TBL] [Abstract][Full Text] [Related]
5. Treatment of cirrhotic ascites.
Schouten J; Michielsen PP
Acta Gastroenterol Belg; 2007; 70(2):217-22. PubMed ID: 17715638
[TBL] [Abstract][Full Text] [Related]
6. Refractory Ascites in Liver Cirrhosis.
Adebayo D; Neong SF; Wong F
Am J Gastroenterol; 2019 Jan; 114(1):40-47. PubMed ID: 29973706
[TBL] [Abstract][Full Text] [Related]
7. [New therapeutic paradigm and concepts for patients with cirrhotic refractory ascites].
Wang SZ; Ding HG
Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):249-253. PubMed ID: 28494541
[TBL] [Abstract][Full Text] [Related]
8. Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.
Tan HK; James PD; Wong F
Dig Dis Sci; 2016 Oct; 61(10):3084-3092. PubMed ID: 27048451
[TBL] [Abstract][Full Text] [Related]
9. Management of ascites in cirrhosis.
Bataller R; Arroyo V; Ginès P
J Gastroenterol Hepatol; 1997 Nov; 12(11):723-33. PubMed ID: 9430037
[TBL] [Abstract][Full Text] [Related]
10. Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis.
Salerno F; Guevara M; Bernardi M; Moreau R; Wong F; Angeli P; Garcia-Tsao G; Lee SS
Liver Int; 2010 Aug; 30(7):937-47. PubMed ID: 20492521
[TBL] [Abstract][Full Text] [Related]
11. Cost-Effectiveness of Transjugular Intrahepatic Portosystemic Shunt versus Large-Volume Paracentesis in Refractory Ascites: Results of a Markov Model Incorporating Individual Patient-Level Meta-Analysis and Nationally Representative Cost Data.
Kwan SW; Allison SK; Gold LS; Shin DS
J Vasc Interv Radiol; 2018 Dec; 29(12):1705-1712. PubMed ID: 30392803
[TBL] [Abstract][Full Text] [Related]
12. TIPS versus paracentesis for cirrhotic patients with refractory ascites.
Saab S; Nieto JM; Lewis SK; Runyon BA
Cochrane Database Syst Rev; 2006 Oct; 2006(4):CD004889. PubMed ID: 17054221
[TBL] [Abstract][Full Text] [Related]
13. Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites.
Bureau C; Thabut D; Oberti F; Dharancy S; Carbonell N; Bouvier A; Mathurin P; Otal P; Cabarrou P; Péron JM; Vinel JP
Gastroenterology; 2017 Jan; 152(1):157-163. PubMed ID: 27663604
[TBL] [Abstract][Full Text] [Related]
14. Management of refractory ascites.
Wong F
Clin Mol Hepatol; 2023 Jan; 29(1):16-32. PubMed ID: 35676862
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and therapy of ascites in liver cirrhosis.
Biecker E
World J Gastroenterol; 2011 Mar; 17(10):1237-48. PubMed ID: 21455322
[TBL] [Abstract][Full Text] [Related]
16. Ascites: diagnosis and management.
Hou W; Sanyal AJ
Med Clin North Am; 2009 Jul; 93(4):801-17, vii. PubMed ID: 19577115
[TBL] [Abstract][Full Text] [Related]
17. Automated low flow pump system for the treatment of refractory ascites: a single-center experience.
Thomas MN; Sauter GH; Gerbes AL; Stangl M; Schiergens TS; Angele M; Werner J; Guba M
Langenbecks Arch Surg; 2015 Dec; 400(8):979-83. PubMed ID: 26566989
[TBL] [Abstract][Full Text] [Related]
18. The transjugular intrahepatic portosystemic shunt for the management of cirrhotic refractory ascites.
Garcia-Tsao G
Nat Clin Pract Gastroenterol Hepatol; 2006 Jul; 3(7):380-9. PubMed ID: 16819501
[TBL] [Abstract][Full Text] [Related]
19. Management of ascites.
Yu AS; Hu KQ
Clin Liver Dis; 2001 May; 5(2):541-68, viii. PubMed ID: 11385975
[TBL] [Abstract][Full Text] [Related]
20. Fluid and electrolyte management of ascites in patients with cirrhosis.
Bass M
Crit Care Nurs Clin North Am; 1998 Dec; 10(4):459-67. PubMed ID: 10326425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
